ERZOFRI

Medicines for human purposes for the treatment of schizophrenia in adults; medicines for human purposes for the treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; chemical preparations for pharmaceutical purposes, namely, for the treatment of schizophrenia in adults; chemical preparations for pharmaceutical purposes, namely, for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; Biochemical medicines for the treatment of schizophrenia in adults; Biochemical medicines for the treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; pharmaceutical preparations for treatment of schizophrenia in adults; pharmaceutical preparations for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; chemico-pharmaceutical preparations for treatment of schizophrenia in adults; chemico-pharmaceutical preparations for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; Injectable pharmaceuticals for treatment of schizophrenia in adults; Injectable pharmaceuticals for treatment of schizoaffective disorder in adults as mono therapy and as an adjunct to mood stabilizers or antidepressants; antidepressants; dressings, medical